These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26907578)

  • 1. Association of MMPs and TIMPs With the Occurrence of Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Liu Y; Xu B; Wu N; Xiang Y; Wu L; Zhang M; Wang J; Chen X; Li Y; Zhong L
    Can J Cardiol; 2016 Jun; 32(6):803-13. PubMed ID: 26907578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.
    Mukherjee R; Akar JG; Wharton JM; Adams DK; McClure CD; Stroud RE; Rice AD; DeSantis SM; Spinale FG; Gold MR
    J Cardiovasc Transl Res; 2013 Aug; 6(4):528-35. PubMed ID: 23722357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
    J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
    Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis.
    Wu N; Chen X; Cai T; Wu L; Xiang Y; Zhang M; Li Y; Song Z; Zhong L
    Can J Cardiol; 2015 Mar; 31(3):278-86. PubMed ID: 25746020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-9 in atrial remodeling in patients with atrial fibrillation.
    Lewkowicz J; Knapp M; Tankiewicz-Kwedlo A; Sawicki R; Kamińska M; Waszkiewicz E; Musiał WJ
    Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):285-91. PubMed ID: 25869465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.
    Wu N; Tong S; Xiang Y; Wu L; Xu B; Zhang Y; Ma X; Li Y; Song Z; Zhong L
    PLoS One; 2015; 10(4):e0124716. PubMed ID: 25884835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
    Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
    Nakano Y; Niida S; Dote K; Takenaka S; Hirao H; Miura F; Ishida M; Shingu T; Sueda T; Yoshizumi M; Chayama K
    J Am Coll Cardiol; 2004 Mar; 43(5):818-25. PubMed ID: 14998623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].
    Wang W; Wu PS; Yang XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1160-2. PubMed ID: 20501421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
    Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
    Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of N-terminal pro-brain natriuretic peptide and new-onset atrial fibrillation in patients with acute coronary syndrome: a systematic review and meta-analysis.
    Gao X; Zeng R; Liao P; Zhu H; Zhang M
    Scand J Clin Lab Invest; 2016 Oct; 76(6):460-4. PubMed ID: 27347749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation.
    Gramley F; Lorenzen J; Plisiene J; Rakauskas M; Benetis R; Schmid M; Autschbach R; Knackstedt C; Schimpf T; Mischke K; Gressner A; Hanrath P; Kelm M; Schauerte P
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1076-82. PubMed ID: 17655664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
    Mühl D; Nagy B; Woth G; Falusi B; Bogár L; Weber G; Lantos J
    J Crit Care; 2011 Dec; 26(6):550-5. PubMed ID: 21530151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
    Lorenzl S; Buerger K; Hampel H; Beal MF
    Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.